Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cronos Group Inc. Director's Dealing 2021

Mar 10, 2021

32126_dirs_2021-03-10_95de1819-5966-4bc7-b18d-07f89542e3de.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cronos Group Inc. (CRON)
CIK: 0001656472
Period of Report: 2021-03-08

Reporting Person: GORENSTEIN MICHAEL RYAN (Director, Executive Chairman)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-03-08 COMMON SHARES M 1200000 $0.9701 Acquired 9632536 Direct
2021-03-08 COMMON SHARES F 410589 $9.5354 Disposed 9221947 Direct
2021-03-09 COMMON SHARES S 185000 $9.9962 Disposed 9036947 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-03-08 COMMON SHARE OPTION (right to buy) $0.9701 M 1200000 Disposed 2021-10-06 COMMON SHARES (1200000.0) Direct

Footnotes

F1: The price reported was converted from the Canadian exercise price of C$1.23 to U.S. dollars using an exchange rate of C$1.00 to US$0.7887 as reported by Bloomberg as of March 5, 2021.

F2: Cronos Group Inc. (the "Company") withheld 410,589 common shares underlying the options for payment of the exercise price and to cover applicable withholding taxes, using the closing price of the Company's common shares on March 5, 2021 of C$12.09 as reported on the Toronto Stock Exchange.

F3: The price reported is in U.S. dollars based on the exchange rate of C$1.00 to US$0.7887 as reported by Bloomberg as of March 5, 2021.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.90 to $10.07, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4.

F5: The options were granted October 6, 2016 and vest in monthly installments over a four-year period.